É. Bonnet

2.8k total citations
89 papers, 1.7k citations indexed

About

É. Bonnet is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, É. Bonnet has authored 89 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 36 papers in Epidemiology and 25 papers in Surgery. Recurrent topics in É. Bonnet's work include Antimicrobial Resistance in Staphylococcus (17 papers), Pneumonia and Respiratory Infections (16 papers) and Orthopedic Infections and Treatments (15 papers). É. Bonnet is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (17 papers), Pneumonia and Respiratory Infections (16 papers) and Orthopedic Infections and Treatments (15 papers). É. Bonnet collaborates with scholars based in France, United States and United Kingdom. É. Bonnet's co-authors include Patrice Massip, B. Marchou, Bertrand Perret, Robert Cohen, Emmanuelle Varon, Corinne Lévy, Bernard Fritzell, Josette Fauvel, A. Bicart-See and Jean‐Bernard Ruidavets and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Infectious Diseases and Critical Care Medicine.

In The Last Decade

É. Bonnet

82 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
É. Bonnet France 22 739 634 407 381 250 89 1.7k
Mary Bavaro United States 20 522 0.7× 635 1.0× 190 0.5× 294 0.8× 65 0.3× 35 1.3k
Szu‐Min Hsieh Taiwan 27 1.5k 2.0× 1.3k 2.0× 377 0.9× 229 0.6× 78 0.3× 162 2.6k
Vicente Pintado Spain 33 1.3k 1.8× 1.5k 2.4× 364 0.9× 170 0.4× 247 1.0× 76 3.2k
Vicenç Falcó Spain 32 1.2k 1.6× 1.6k 2.6× 709 1.7× 319 0.8× 108 0.4× 150 3.0k
José M. Gatell Spain 28 1.5k 2.0× 933 1.5× 827 2.0× 573 1.5× 110 0.4× 43 2.3k
Francesco Chiodo Italy 31 1.5k 2.0× 1.0k 1.7× 759 1.9× 769 2.0× 88 0.4× 215 3.1k
C. Arvieux France 23 648 0.9× 684 1.1× 284 0.7× 160 0.4× 44 0.2× 102 1.7k
Limangeni Mankhambo Malawi 17 523 0.7× 590 0.9× 364 0.9× 133 0.3× 170 0.7× 29 1.3k
Katia Boggian Switzerland 21 1.4k 1.9× 1.4k 2.2× 456 1.1× 358 0.9× 52 0.2× 58 2.4k
Diana Averbuch Israel 25 716 1.0× 967 1.5× 212 0.5× 127 0.3× 112 0.4× 92 2.2k

Countries citing papers authored by É. Bonnet

Since Specialization
Citations

This map shows the geographic impact of É. Bonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Bonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Bonnet more than expected).

Fields of papers citing papers by É. Bonnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Bonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Bonnet. The network helps show where É. Bonnet may publish in the future.

Co-authorship network of co-authors of É. Bonnet

This figure shows the co-authorship network connecting the top 25 collaborators of É. Bonnet. A scholar is included among the top collaborators of É. Bonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Bonnet. É. Bonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diamantis, S., É. Bonnet, Virginie Prendki, et al.. (2025). Aspiration pneumonia guidelines – Société de Pathologie Infectieuse de Langue Française 2025. Infectious Diseases Now. 55(5). 105081–105081.
2.
Combes, Nicolas, et al.. (2025). Transcatheter aortic valve implantation: Association between skin flora and infective endocarditis?. Archives of cardiovascular diseases. 118(4). 241–247.
3.
Couzigou, C., et al.. (2024). Microbiological Profile of Instrumented Spinal Infections: 10-Year Study at a French Spine Center. Antibiotics. 13(9). 791–791. 1 indexed citations
4.
Bonnet, É., Vincent Cattoir, Catherine Chirouze, et al.. (2024). Antibiotic therapy and prophylaxis of infective endocarditis – A SPILF-AEPEI position statement on the ESC 2023 guidelines. Infectious Diseases Now. 55(1). 105011–105011. 1 indexed citations
5.
Houeijeh, Ali, É. Bonnet, Clément Karsenty, et al.. (2023). Infective endocarditis after transcatheter pulmonary valve implantation in patients with congenital heart disease: Distinctive features. Archives of cardiovascular diseases. 116(3). 159–166. 8 indexed citations
6.
Charbonneau, Hélène, et al.. (2023). Chlamydia psittaci endocarditis: A case report and literature review. Infectious Diseases Now. 53(5). 104687–104687. 3 indexed citations
7.
Bonnet, É., Laurence Maulin, Éric Senneville, et al.. (2023). Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) – 2023 SPILF. Infectious Diseases Now. 54(1). 104832–104832. 8 indexed citations
8.
Stahl, J.‐P., Bernard Castan, É. Bonnet, et al.. (2022). Utilization of macrolides. State of the art 2022 Spilf and GPIP. Infectious Diseases Now. 52(5). 252–266.
9.
Charbonneau, Hélène, et al.. (2022). Comparable clinical course between coagulase-negative staphylococcal and Staphylococcus aureus endocarditis. Infection. 50(2). 483–490. 4 indexed citations
10.
Gauzit, R., Bernard Castan, É. Bonnet, et al.. (2021). Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations. Infectious Diseases Now. 51(2). 114–139. 20 indexed citations
11.
Hascoët, Sébastien, et al.. (2021). Endocarditis due to Gram Positive Anaerobic Cocci: First report of Peptoniphilus indolicus endocarditis and literature review. Clinical Infection in Practice. 11. 100073–100073. 1 indexed citations
12.
Bonnet, É., C. Chambrier, Alexandre Charmillon, et al.. (2021). Antibiotic lock therapy for the conservative treatment of long-term intravenous catheter-related infections in adults and children: When and how to proceed? Guidelines for clinical practice 2020. Infectious Diseases Now. 51(3). 236–246. 17 indexed citations
13.
Blanc, Philippe, et al.. (2019). The use of labelled leucocyte scintigraphy to evaluate chronic periprosthetic joint infections: a retrospective multicentre study on 168 patients. European Journal of Clinical Microbiology & Infectious Diseases. 38(9). 1625–1631. 16 indexed citations
14.
Saeed, Kordo, Silvano Esposito, Ian M. Gould, et al.. (2018). Hot topics in necrotising skin and soft tissue infections. International Journal of Antimicrobial Agents. 52(1). 1–10. 20 indexed citations
15.
Bicart-See, A., et al.. (2018). Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections. Epidemiology and Infection. 146(14). 1771–1776. 34 indexed citations
16.
Bonnet, É., et al.. (2016). Endocardite à Finegoldia magna. Médecine et Maladies Infectieuses. 47(1). 65–67. 4 indexed citations
17.
Bonnet, É., Jacques Bernard, Josette Fauvel, et al.. (2008). Association of APOC3 Polymorphisms with Both Dyslipidemia and Lipoatrophy in HAART-Receiving Patients. AIDS Research and Human Retroviruses. 24(2). 169–171. 19 indexed citations
18.
Reinert, Philippe, Malika Benkerrou, Mariane de Montalembert, et al.. (2007). Immunogenicity and Safety of a Pneumococcal Conjugate 7-Valent Vaccine in Infants With Sickle Cell Disease. The Pediatric Infectious Disease Journal. 26(12). 1105–1109. 21 indexed citations
19.
Malavaud, Bernard, et al.. (2000). Increased Incidence of Indinavir Nephrolithiasis in Patients with Hepatitis B or C Virus Infection. Antiviral Therapy. 5(1). 3–5. 39 indexed citations
20.
Bonnet, É., et al.. (1999). Neurotoxicity of Artemisinin: Possible Counseling and Treatment of Side Effects. Clinical Infectious Diseases. 28(6). 1330–1331. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Bavaro Breakdown of academic impact, for papers by Szu‐Min Hsieh Breakdown of academic impact, for papers by Vicente Pintado Breakdown of academic impact, for papers by Vicenç Falcó Breakdown of academic impact, for papers by José M. Gatell Breakdown of academic impact, for papers by Francesco Chiodo Breakdown of academic impact, for papers by C. Arvieux Breakdown of academic impact, for papers by Limangeni Mankhambo Breakdown of academic impact, for papers by Katia Boggian Breakdown of academic impact, for papers by Diana Averbuch
Rankless by CCL
2026